Appeal No. 95-0976
Application No. 07/936,558
13. An antibiotic composition comprising therapeutic
amount of a compound of Claim 1 in a pharmaceutically
acceptable carrier.
The references relied upon by the examiner are:
Sandoz (Belgium)
'310 Pat. 851,310 Aug. 10, 1977
Sandoz (Belgium)
'067 Pat. 859,067 Mar. 28, 1978
Schmatz 5,166,135 Nov. 24, 1992
Claim 1 stands rejected under 35 U.S.C. § 112, first
paragraph, as failing to provide an enabling disclosure. We
reverse this rejection.
Claims 1-14 stand rejected under 35 U.S.C. § 103 over
Schmatz or '310 Pat. in combination with '067 Pat. We reverse
this rejection.
Claims 1-14 stand provisionally rejected under the
judicially created doctrine of obviousness-type double
patenting
as lacking patentable distinction over (1) Claims 1-11 and 13
or (2) Claims 1-4 or (3) Claims 3-20 or (4) Claims 4-7 or (5)
Claims 1-13 or (6) Claims 1-10 or (7) Claims 1-9 of copending
applications (1) 07/936,561; (2) 07/963,332; (3) 07/775,774;
7
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007